Weill Cornell Medicine’s Daedalus Fund for Innovation is designed to advance early stage applied and translational research projects that have significant commercial potential. They currently fund our multi-modal imaging studies for TBI.
The Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative is aimed at revolutionizing our understanding of the human brain. They currently fund our central thalamic stimulation studies.
The NIH-NINDS supports work that aims to decrease the burden of neurological conditions. They currently fund our work in thalamic stimulation.
The NIH-NICHD supports work that aims to understand and prevent TBI, and to improve outcomes for people affected by TBI and related conditions. They currently fund our work in assessing minimally conscious patients using various imaging techniques.
The JSMF supports work that aims to “improve the quality of life” through research and scholarship. They currently fund a collaborative, multi-center study looking to develop validated tools to properly diagnose and assess patients across the disorders of consciousness spectrum. JSMF also supports our work examining the role of the dopaminergic system in disorders of consciousness and mechanisms of recovery.
The CTSC consortium that aims to bring research across a wide range of fields from bench to bedside through multi-institutional, collaborative work. The CTSC currently funds our work in bringing patients with disorders of consciousness to New York Presbyterian for observational research. The CTSC also supports our work in learning about surrogate decision-making for patients with brain injury.
The Dana Foundation is a private philanthropic organization that supports brain research through grants, publications, and educational programs. The foundation has supported our studies looking at the family/surrogate experience and surrogate decision-making processes.
The Katz Foundation is a private non-profit helmed by Jerold B. Katz, a businessman and philanthropist from Texas. Mr. Katz developed an interest in neuroscience and research after his son, Lenny, was in a car accident and sustained a severe brain injury. Since coming across work done by CASBI co-founders, Drs. Schiff and Fins, Mr. Katz has made many generous gifts in support of the consortium’s work. Dr. Schiff was also named the first Jerold B. Katz Professor of Neurology and Neuroscience. To date, The Foundation’s contributions have supported all aspects of CASBI’s work.
The Buster Family Foundation is a private non-profit organization. The foundation has supported our studies looking at the family/surrogate experience and surrogate decision-making processes, as well as neuroimaging research.
RWJF supports initiatives that respond to health challenges facing our country, including those in the public health and bioethics sectors. Dr. Fins is a recipient of a Robert Wood Johnson Foundation Investigator Award in Health Policy Research.
The Lounsbery Foundation supports work in the science and technology sectors. The foundation has supported the collaborative efforts of the CASBI team and Rockefeller University Hospital to create a unit dedicated to the study of patients with disorders of consciousness.
DARPA is a governmental agency that works as the Department of Defense’s primary source of strategic and innovative technologies. DARPA currently funds our research in attention enhancement through computer based programs.
This scholar award, established in 2009, is given to junior or midlevel Weill Cornell faculty focusing on clinical and translational research. The award is also intended to provide protected research time to acquire preliminary data before applying for larger federal funding. This award supports Henning Voss’s work at the Citigroup Biomedical Imaging Center.